Cost-minimization analysis of pneumonia treatment in Indonesia

Pneumonia is one of the significant causes death in developing countries, including Indonesia. As capital West Java, Bandung cities with highest pneumonia cases this province. The objective study was to conduct cost-minimization analysis treatment Indonesia by using private hospitals as a reference case. use cefuroxime and ceftizoxime considered adult hospitalized patients. In addition, ampicillin-sulbactam ceftriaxone usage compared pediatric A cross-sectional descriptive applied collecting data retrospectively from medical records patients who met inclusion criteria at January 2017 December 2018. We following criteria: (i) (> 20 years old) (0–5 were diagnosed pneumonia; (ii) received or antibiotic therapy therapy. excluded any other co-morbidities did not complete treatment. result showed that drug cost primary contributor total calculated average $149.39 $193.05, respectively, $202.83 $192.77, respectively. also estimated LoS group 3.8 4.1 days, 3.9 5.3 conclusion, treat would require less yield shorter than cefuroxime. Using higher costs ceftriaxone.